Frequency and Intensity of Postoperative Surveillance After Curative Treatment of Pancreatic Cancer: A Cost-Effectiveness Analysis

Fear of Cancer Recurrence after Curative Pancreatectomy: A Cross-sectional Study in Survivors of Pancreatic and Periampullary Tumors

(2012) Maria Q. B. Petzel et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer

(2012) Matthew H. G. Katz et al.   ARCHIVES OF SURGERY

Selective Reoperation for Locally Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma Following Primary Pancreatic Resection

(2012) Ryan M. Thomas et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy

(2012) Ching-Wei D. Tzeng et al.   HPB

Surveillance of Pancreatic Cancer Patients after Surgical Resection

(2011) Kristin M. Sheffield et al.   ANNALS OF SURGICAL ONCOLOGY

Melanomas Detected in a Follow-up Program Compared With Melanomas Referred to a Melanoma Unit

(2011) Gabriel Salerni et al.   ARCHIVES OF DERMATOLOGY

Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer

(2011) James D. Murphy et al.   CANCER

Assessment of Quality of Cancer-Related Follow-Up Care From the Cancer Survivor's Perspective

(2011) Neeraj K. Arora et al.   JOURNAL OF CLINICAL ONCOLOGY

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

(2010) C. A. Thompson et al.   ANNALS OF ONCOLOGY

Cost-Utility Estimation of Surgical Treatment of Pancreatic Carcinoma Aimed at Cure

(2010) David Ljungman et al.   WORLD JOURNAL OF SURGERY

Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

(2009) Matthew H. G. Katz et al.   ANNALS OF SURGICAL ONCOLOGY

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

(2009) R Scott Braithwaite et al.   MEDICAL CARE

Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer

(2008) Rosa F. Hwang et al.   ANNALS OF SURGICAL ONCOLOGY

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY

Determining Pattern of Recurrence Following Pancreaticoduodenectomy and Adjuvant 5-Flurouracil-Based Chemoradiation Therapy: Effect of Number of Metastatic Lymph Nodes and Lymph Node Ratio

(2008) Bolanle Asiyanbola et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS